Medical Care
Global Nutraceutical CDMO Market Research Report 2025
- Jul 10, 25
- ID: 365093
- Pages: 95
- Figures: 100
- Views: 10
The global market for Nutraceutical CDMO was valued at US$ 35741 million in the year 2024 and is projected to reach a revised size of US$ 50181 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Nutraceutical CDMOs (Contract Development and Manufacturing Organizations) are specialized third-party service providers that offer end-to-end solutions for nutraceutical companies, including formulation development, ingredient sourcing, process optimization, dosage form design (e.g., tablets, softgels, powders, functional beverages), GMP-compliant manufacturing, packaging, and regulatory support. As the nutraceutical industry experiences rapid growth and increasing consumer demand for health supplements and functional foods, CDMOs enable brand owners to accelerate product development, reduce operational burden, and focus on marketing and distribution. Nutraceutical CDMOs are becoming key players in the global value chain, particularly across North America, Europe, and Asia-Pacific.
North American market for Nutraceutical CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Nutraceutical CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Nutraceutical CDMO in Small Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Nutraceutical CDMO include Catalent, Lonza, Aenova Group, Akums Drugs and Pharmaceutical, BASF SE, Sirio Pharm, Pharmavite, Nature's Products, PLT Health Solutions, Glanbia Nutritionals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nutraceutical CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nutraceutical CDMO.
The Nutraceutical CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nutraceutical CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nutraceutical CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Catalent
Lonza
Aenova Group
Akums Drugs and Pharmaceutical
BASF SE
Sirio Pharm
Pharmavite
Nature's Products
PLT Health Solutions
Glanbia Nutritionals
Recipharm AB
B&D Nutritional Ingredients
NutraScience Labs
Vitakem Nutraceutical
Procaps Group
Iprona
Nutrilo GmbH
Atlantic Essential Products
ProTec Nutra
Nutraceuticals International
Segment by Type
Tablets & Capsules
Powder
Softgel
Liquid Formulations
Other
Segment by Application
Small Companies
Mid-sized Companies
Large Companies
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nutraceutical CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Nutraceutical CDMOs (Contract Development and Manufacturing Organizations) are specialized third-party service providers that offer end-to-end solutions for nutraceutical companies, including formulation development, ingredient sourcing, process optimization, dosage form design (e.g., tablets, softgels, powders, functional beverages), GMP-compliant manufacturing, packaging, and regulatory support. As the nutraceutical industry experiences rapid growth and increasing consumer demand for health supplements and functional foods, CDMOs enable brand owners to accelerate product development, reduce operational burden, and focus on marketing and distribution. Nutraceutical CDMOs are becoming key players in the global value chain, particularly across North America, Europe, and Asia-Pacific.
North American market for Nutraceutical CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Nutraceutical CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Nutraceutical CDMO in Small Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Nutraceutical CDMO include Catalent, Lonza, Aenova Group, Akums Drugs and Pharmaceutical, BASF SE, Sirio Pharm, Pharmavite, Nature's Products, PLT Health Solutions, Glanbia Nutritionals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nutraceutical CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nutraceutical CDMO.
The Nutraceutical CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nutraceutical CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nutraceutical CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Catalent
Lonza
Aenova Group
Akums Drugs and Pharmaceutical
BASF SE
Sirio Pharm
Pharmavite
Nature's Products
PLT Health Solutions
Glanbia Nutritionals
Recipharm AB
B&D Nutritional Ingredients
NutraScience Labs
Vitakem Nutraceutical
Procaps Group
Iprona
Nutrilo GmbH
Atlantic Essential Products
ProTec Nutra
Nutraceuticals International
Segment by Type
Tablets & Capsules
Powder
Softgel
Liquid Formulations
Other
Segment by Application
Small Companies
Mid-sized Companies
Large Companies
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nutraceutical CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nutraceutical CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tablets & Capsules
1.2.3 Powder
1.2.4 Softgel
1.2.5 Liquid Formulations
1.2.6 Other
1.3 Market by Application
1.3.1 Global Nutraceutical CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Small Companies
1.3.3 Mid-sized Companies
1.3.4 Large Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nutraceutical CDMO Market Perspective (2020-2031)
2.2 Global Nutraceutical CDMO Growth Trends by Region
2.2.1 Global Nutraceutical CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nutraceutical CDMO Historic Market Size by Region (2020-2025)
2.2.3 Nutraceutical CDMO Forecasted Market Size by Region (2026-2031)
2.3 Nutraceutical CDMO Market Dynamics
2.3.1 Nutraceutical CDMO Industry Trends
2.3.2 Nutraceutical CDMO Market Drivers
2.3.3 Nutraceutical CDMO Market Challenges
2.3.4 Nutraceutical CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nutraceutical CDMO Players by Revenue
3.1.1 Global Top Nutraceutical CDMO Players by Revenue (2020-2025)
3.1.2 Global Nutraceutical CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Top Nutraceutical CDMO Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nutraceutical CDMO Revenue
3.4 Global Nutraceutical CDMO Market Concentration Ratio
3.4.1 Global Nutraceutical CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nutraceutical CDMO Revenue in 2024
3.5 Global Key Players of Nutraceutical CDMO Head office and Area Served
3.6 Global Key Players of Nutraceutical CDMO, Product and Application
3.7 Global Key Players of Nutraceutical CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nutraceutical CDMO Breakdown Data by Type
4.1 Global Nutraceutical CDMO Historic Market Size by Type (2020-2025)
4.2 Global Nutraceutical CDMO Forecasted Market Size by Type (2026-2031)
5 Nutraceutical CDMO Breakdown Data by Application
5.1 Global Nutraceutical CDMO Historic Market Size by Application (2020-2025)
5.2 Global Nutraceutical CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nutraceutical CDMO Market Size (2020-2031)
6.2 North America Nutraceutical CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nutraceutical CDMO Market Size by Country (2020-2025)
6.4 North America Nutraceutical CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nutraceutical CDMO Market Size (2020-2031)
7.2 Europe Nutraceutical CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nutraceutical CDMO Market Size by Country (2020-2025)
7.4 Europe Nutraceutical CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Nutraceutical CDMO Market Size (2020-2031)
8.2 Asia-Pacific Nutraceutical CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nutraceutical CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Nutraceutical CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Nutraceutical CDMO Market Size (2020-2031)
9.2 Latin America Nutraceutical CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nutraceutical CDMO Market Size by Country (2020-2025)
9.4 Latin America Nutraceutical CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nutraceutical CDMO Market Size (2020-2031)
10.2 Middle East & Africa Nutraceutical CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nutraceutical CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Nutraceutical CDMO Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent Nutraceutical CDMO Introduction
11.1.4 Catalent Revenue in Nutraceutical CDMO Business (2020-2025)
11.1.5 Catalent Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Nutraceutical CDMO Introduction
11.2.4 Lonza Revenue in Nutraceutical CDMO Business (2020-2025)
11.2.5 Lonza Recent Development
11.3 Aenova Group
11.3.1 Aenova Group Company Details
11.3.2 Aenova Group Business Overview
11.3.3 Aenova Group Nutraceutical CDMO Introduction
11.3.4 Aenova Group Revenue in Nutraceutical CDMO Business (2020-2025)
11.3.5 Aenova Group Recent Development
11.4 Akums Drugs and Pharmaceutical
11.4.1 Akums Drugs and Pharmaceutical Company Details
11.4.2 Akums Drugs and Pharmaceutical Business Overview
11.4.3 Akums Drugs and Pharmaceutical Nutraceutical CDMO Introduction
11.4.4 Akums Drugs and Pharmaceutical Revenue in Nutraceutical CDMO Business (2020-2025)
11.4.5 Akums Drugs and Pharmaceutical Recent Development
11.5 BASF SE
11.5.1 BASF SE Company Details
11.5.2 BASF SE Business Overview
11.5.3 BASF SE Nutraceutical CDMO Introduction
11.5.4 BASF SE Revenue in Nutraceutical CDMO Business (2020-2025)
11.5.5 BASF SE Recent Development
11.6 Sirio Pharm
11.6.1 Sirio Pharm Company Details
11.6.2 Sirio Pharm Business Overview
11.6.3 Sirio Pharm Nutraceutical CDMO Introduction
11.6.4 Sirio Pharm Revenue in Nutraceutical CDMO Business (2020-2025)
11.6.5 Sirio Pharm Recent Development
11.7 Pharmavite
11.7.1 Pharmavite Company Details
11.7.2 Pharmavite Business Overview
11.7.3 Pharmavite Nutraceutical CDMO Introduction
11.7.4 Pharmavite Revenue in Nutraceutical CDMO Business (2020-2025)
11.7.5 Pharmavite Recent Development
11.8 Nature's Products
11.8.1 Nature's Products Company Details
11.8.2 Nature's Products Business Overview
11.8.3 Nature's Products Nutraceutical CDMO Introduction
11.8.4 Nature's Products Revenue in Nutraceutical CDMO Business (2020-2025)
11.8.5 Nature's Products Recent Development
11.9 PLT Health Solutions
11.9.1 PLT Health Solutions Company Details
11.9.2 PLT Health Solutions Business Overview
11.9.3 PLT Health Solutions Nutraceutical CDMO Introduction
11.9.4 PLT Health Solutions Revenue in Nutraceutical CDMO Business (2020-2025)
11.9.5 PLT Health Solutions Recent Development
11.10 Glanbia Nutritionals
11.10.1 Glanbia Nutritionals Company Details
11.10.2 Glanbia Nutritionals Business Overview
11.10.3 Glanbia Nutritionals Nutraceutical CDMO Introduction
11.10.4 Glanbia Nutritionals Revenue in Nutraceutical CDMO Business (2020-2025)
11.10.5 Glanbia Nutritionals Recent Development
11.11 Recipharm AB
11.11.1 Recipharm AB Company Details
11.11.2 Recipharm AB Business Overview
11.11.3 Recipharm AB Nutraceutical CDMO Introduction
11.11.4 Recipharm AB Revenue in Nutraceutical CDMO Business (2020-2025)
11.11.5 Recipharm AB Recent Development
11.12 B&D Nutritional Ingredients
11.12.1 B&D Nutritional Ingredients Company Details
11.12.2 B&D Nutritional Ingredients Business Overview
11.12.3 B&D Nutritional Ingredients Nutraceutical CDMO Introduction
11.12.4 B&D Nutritional Ingredients Revenue in Nutraceutical CDMO Business (2020-2025)
11.12.5 B&D Nutritional Ingredients Recent Development
11.13 NutraScience Labs
11.13.1 NutraScience Labs Company Details
11.13.2 NutraScience Labs Business Overview
11.13.3 NutraScience Labs Nutraceutical CDMO Introduction
11.13.4 NutraScience Labs Revenue in Nutraceutical CDMO Business (2020-2025)
11.13.5 NutraScience Labs Recent Development
11.14 Vitakem Nutraceutical
11.14.1 Vitakem Nutraceutical Company Details
11.14.2 Vitakem Nutraceutical Business Overview
11.14.3 Vitakem Nutraceutical Nutraceutical CDMO Introduction
11.14.4 Vitakem Nutraceutical Revenue in Nutraceutical CDMO Business (2020-2025)
11.14.5 Vitakem Nutraceutical Recent Development
11.15 Procaps Group
11.15.1 Procaps Group Company Details
11.15.2 Procaps Group Business Overview
11.15.3 Procaps Group Nutraceutical CDMO Introduction
11.15.4 Procaps Group Revenue in Nutraceutical CDMO Business (2020-2025)
11.15.5 Procaps Group Recent Development
11.16 Iprona
11.16.1 Iprona Company Details
11.16.2 Iprona Business Overview
11.16.3 Iprona Nutraceutical CDMO Introduction
11.16.4 Iprona Revenue in Nutraceutical CDMO Business (2020-2025)
11.16.5 Iprona Recent Development
11.17 Nutrilo GmbH
11.17.1 Nutrilo GmbH Company Details
11.17.2 Nutrilo GmbH Business Overview
11.17.3 Nutrilo GmbH Nutraceutical CDMO Introduction
11.17.4 Nutrilo GmbH Revenue in Nutraceutical CDMO Business (2020-2025)
11.17.5 Nutrilo GmbH Recent Development
11.18 Atlantic Essential Products
11.18.1 Atlantic Essential Products Company Details
11.18.2 Atlantic Essential Products Business Overview
11.18.3 Atlantic Essential Products Nutraceutical CDMO Introduction
11.18.4 Atlantic Essential Products Revenue in Nutraceutical CDMO Business (2020-2025)
11.18.5 Atlantic Essential Products Recent Development
11.19 ProTec Nutra
11.19.1 ProTec Nutra Company Details
11.19.2 ProTec Nutra Business Overview
11.19.3 ProTec Nutra Nutraceutical CDMO Introduction
11.19.4 ProTec Nutra Revenue in Nutraceutical CDMO Business (2020-2025)
11.19.5 ProTec Nutra Recent Development
11.20 Nutraceuticals International
11.20.1 Nutraceuticals International Company Details
11.20.2 Nutraceuticals International Business Overview
11.20.3 Nutraceuticals International Nutraceutical CDMO Introduction
11.20.4 Nutraceuticals International Revenue in Nutraceutical CDMO Business (2020-2025)
11.20.5 Nutraceuticals International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nutraceutical CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tablets & Capsules
1.2.3 Powder
1.2.4 Softgel
1.2.5 Liquid Formulations
1.2.6 Other
1.3 Market by Application
1.3.1 Global Nutraceutical CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Small Companies
1.3.3 Mid-sized Companies
1.3.4 Large Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nutraceutical CDMO Market Perspective (2020-2031)
2.2 Global Nutraceutical CDMO Growth Trends by Region
2.2.1 Global Nutraceutical CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nutraceutical CDMO Historic Market Size by Region (2020-2025)
2.2.3 Nutraceutical CDMO Forecasted Market Size by Region (2026-2031)
2.3 Nutraceutical CDMO Market Dynamics
2.3.1 Nutraceutical CDMO Industry Trends
2.3.2 Nutraceutical CDMO Market Drivers
2.3.3 Nutraceutical CDMO Market Challenges
2.3.4 Nutraceutical CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nutraceutical CDMO Players by Revenue
3.1.1 Global Top Nutraceutical CDMO Players by Revenue (2020-2025)
3.1.2 Global Nutraceutical CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Top Nutraceutical CDMO Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nutraceutical CDMO Revenue
3.4 Global Nutraceutical CDMO Market Concentration Ratio
3.4.1 Global Nutraceutical CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nutraceutical CDMO Revenue in 2024
3.5 Global Key Players of Nutraceutical CDMO Head office and Area Served
3.6 Global Key Players of Nutraceutical CDMO, Product and Application
3.7 Global Key Players of Nutraceutical CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nutraceutical CDMO Breakdown Data by Type
4.1 Global Nutraceutical CDMO Historic Market Size by Type (2020-2025)
4.2 Global Nutraceutical CDMO Forecasted Market Size by Type (2026-2031)
5 Nutraceutical CDMO Breakdown Data by Application
5.1 Global Nutraceutical CDMO Historic Market Size by Application (2020-2025)
5.2 Global Nutraceutical CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nutraceutical CDMO Market Size (2020-2031)
6.2 North America Nutraceutical CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nutraceutical CDMO Market Size by Country (2020-2025)
6.4 North America Nutraceutical CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nutraceutical CDMO Market Size (2020-2031)
7.2 Europe Nutraceutical CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nutraceutical CDMO Market Size by Country (2020-2025)
7.4 Europe Nutraceutical CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Nutraceutical CDMO Market Size (2020-2031)
8.2 Asia-Pacific Nutraceutical CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nutraceutical CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Nutraceutical CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Nutraceutical CDMO Market Size (2020-2031)
9.2 Latin America Nutraceutical CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nutraceutical CDMO Market Size by Country (2020-2025)
9.4 Latin America Nutraceutical CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nutraceutical CDMO Market Size (2020-2031)
10.2 Middle East & Africa Nutraceutical CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nutraceutical CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Nutraceutical CDMO Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent Nutraceutical CDMO Introduction
11.1.4 Catalent Revenue in Nutraceutical CDMO Business (2020-2025)
11.1.5 Catalent Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Nutraceutical CDMO Introduction
11.2.4 Lonza Revenue in Nutraceutical CDMO Business (2020-2025)
11.2.5 Lonza Recent Development
11.3 Aenova Group
11.3.1 Aenova Group Company Details
11.3.2 Aenova Group Business Overview
11.3.3 Aenova Group Nutraceutical CDMO Introduction
11.3.4 Aenova Group Revenue in Nutraceutical CDMO Business (2020-2025)
11.3.5 Aenova Group Recent Development
11.4 Akums Drugs and Pharmaceutical
11.4.1 Akums Drugs and Pharmaceutical Company Details
11.4.2 Akums Drugs and Pharmaceutical Business Overview
11.4.3 Akums Drugs and Pharmaceutical Nutraceutical CDMO Introduction
11.4.4 Akums Drugs and Pharmaceutical Revenue in Nutraceutical CDMO Business (2020-2025)
11.4.5 Akums Drugs and Pharmaceutical Recent Development
11.5 BASF SE
11.5.1 BASF SE Company Details
11.5.2 BASF SE Business Overview
11.5.3 BASF SE Nutraceutical CDMO Introduction
11.5.4 BASF SE Revenue in Nutraceutical CDMO Business (2020-2025)
11.5.5 BASF SE Recent Development
11.6 Sirio Pharm
11.6.1 Sirio Pharm Company Details
11.6.2 Sirio Pharm Business Overview
11.6.3 Sirio Pharm Nutraceutical CDMO Introduction
11.6.4 Sirio Pharm Revenue in Nutraceutical CDMO Business (2020-2025)
11.6.5 Sirio Pharm Recent Development
11.7 Pharmavite
11.7.1 Pharmavite Company Details
11.7.2 Pharmavite Business Overview
11.7.3 Pharmavite Nutraceutical CDMO Introduction
11.7.4 Pharmavite Revenue in Nutraceutical CDMO Business (2020-2025)
11.7.5 Pharmavite Recent Development
11.8 Nature's Products
11.8.1 Nature's Products Company Details
11.8.2 Nature's Products Business Overview
11.8.3 Nature's Products Nutraceutical CDMO Introduction
11.8.4 Nature's Products Revenue in Nutraceutical CDMO Business (2020-2025)
11.8.5 Nature's Products Recent Development
11.9 PLT Health Solutions
11.9.1 PLT Health Solutions Company Details
11.9.2 PLT Health Solutions Business Overview
11.9.3 PLT Health Solutions Nutraceutical CDMO Introduction
11.9.4 PLT Health Solutions Revenue in Nutraceutical CDMO Business (2020-2025)
11.9.5 PLT Health Solutions Recent Development
11.10 Glanbia Nutritionals
11.10.1 Glanbia Nutritionals Company Details
11.10.2 Glanbia Nutritionals Business Overview
11.10.3 Glanbia Nutritionals Nutraceutical CDMO Introduction
11.10.4 Glanbia Nutritionals Revenue in Nutraceutical CDMO Business (2020-2025)
11.10.5 Glanbia Nutritionals Recent Development
11.11 Recipharm AB
11.11.1 Recipharm AB Company Details
11.11.2 Recipharm AB Business Overview
11.11.3 Recipharm AB Nutraceutical CDMO Introduction
11.11.4 Recipharm AB Revenue in Nutraceutical CDMO Business (2020-2025)
11.11.5 Recipharm AB Recent Development
11.12 B&D Nutritional Ingredients
11.12.1 B&D Nutritional Ingredients Company Details
11.12.2 B&D Nutritional Ingredients Business Overview
11.12.3 B&D Nutritional Ingredients Nutraceutical CDMO Introduction
11.12.4 B&D Nutritional Ingredients Revenue in Nutraceutical CDMO Business (2020-2025)
11.12.5 B&D Nutritional Ingredients Recent Development
11.13 NutraScience Labs
11.13.1 NutraScience Labs Company Details
11.13.2 NutraScience Labs Business Overview
11.13.3 NutraScience Labs Nutraceutical CDMO Introduction
11.13.4 NutraScience Labs Revenue in Nutraceutical CDMO Business (2020-2025)
11.13.5 NutraScience Labs Recent Development
11.14 Vitakem Nutraceutical
11.14.1 Vitakem Nutraceutical Company Details
11.14.2 Vitakem Nutraceutical Business Overview
11.14.3 Vitakem Nutraceutical Nutraceutical CDMO Introduction
11.14.4 Vitakem Nutraceutical Revenue in Nutraceutical CDMO Business (2020-2025)
11.14.5 Vitakem Nutraceutical Recent Development
11.15 Procaps Group
11.15.1 Procaps Group Company Details
11.15.2 Procaps Group Business Overview
11.15.3 Procaps Group Nutraceutical CDMO Introduction
11.15.4 Procaps Group Revenue in Nutraceutical CDMO Business (2020-2025)
11.15.5 Procaps Group Recent Development
11.16 Iprona
11.16.1 Iprona Company Details
11.16.2 Iprona Business Overview
11.16.3 Iprona Nutraceutical CDMO Introduction
11.16.4 Iprona Revenue in Nutraceutical CDMO Business (2020-2025)
11.16.5 Iprona Recent Development
11.17 Nutrilo GmbH
11.17.1 Nutrilo GmbH Company Details
11.17.2 Nutrilo GmbH Business Overview
11.17.3 Nutrilo GmbH Nutraceutical CDMO Introduction
11.17.4 Nutrilo GmbH Revenue in Nutraceutical CDMO Business (2020-2025)
11.17.5 Nutrilo GmbH Recent Development
11.18 Atlantic Essential Products
11.18.1 Atlantic Essential Products Company Details
11.18.2 Atlantic Essential Products Business Overview
11.18.3 Atlantic Essential Products Nutraceutical CDMO Introduction
11.18.4 Atlantic Essential Products Revenue in Nutraceutical CDMO Business (2020-2025)
11.18.5 Atlantic Essential Products Recent Development
11.19 ProTec Nutra
11.19.1 ProTec Nutra Company Details
11.19.2 ProTec Nutra Business Overview
11.19.3 ProTec Nutra Nutraceutical CDMO Introduction
11.19.4 ProTec Nutra Revenue in Nutraceutical CDMO Business (2020-2025)
11.19.5 ProTec Nutra Recent Development
11.20 Nutraceuticals International
11.20.1 Nutraceuticals International Company Details
11.20.2 Nutraceuticals International Business Overview
11.20.3 Nutraceuticals International Nutraceutical CDMO Introduction
11.20.4 Nutraceuticals International Revenue in Nutraceutical CDMO Business (2020-2025)
11.20.5 Nutraceuticals International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Nutraceutical CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Tablets & Capsules
Table 3. Key Players of Powder
Table 4. Key Players of Softgel
Table 5. Key Players of Liquid Formulations
Table 6. Key Players of Other
Table 7. Global Nutraceutical CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Nutraceutical CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Nutraceutical CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Nutraceutical CDMO Market Share by Region (2020-2025)
Table 11. Global Nutraceutical CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Nutraceutical CDMO Market Share by Region (2026-2031)
Table 13. Nutraceutical CDMO Market Trends
Table 14. Nutraceutical CDMO Market Drivers
Table 15. Nutraceutical CDMO Market Challenges
Table 16. Nutraceutical CDMO Market Restraints
Table 17. Global Nutraceutical CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Nutraceutical CDMO Market Share by Players (2020-2025)
Table 19. Global Top Nutraceutical CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nutraceutical CDMO as of 2024)
Table 20. Ranking of Global Top Nutraceutical CDMO Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Nutraceutical CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Nutraceutical CDMO, Headquarters and Area Served
Table 23. Global Key Players of Nutraceutical CDMO, Product and Application
Table 24. Global Key Players of Nutraceutical CDMO, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nutraceutical CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Nutraceutical CDMO Revenue Market Share by Type (2020-2025)
Table 28. Global Nutraceutical CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Nutraceutical CDMO Revenue Market Share by Type (2026-2031)
Table 30. Global Nutraceutical CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Nutraceutical CDMO Revenue Market Share by Application (2020-2025)
Table 32. Global Nutraceutical CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Nutraceutical CDMO Revenue Market Share by Application (2026-2031)
Table 34. North America Nutraceutical CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Nutraceutical CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Nutraceutical CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Nutraceutical CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Nutraceutical CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Nutraceutical CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Nutraceutical CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Nutraceutical CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Nutraceutical CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Nutraceutical CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Nutraceutical CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Nutraceutical CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Nutraceutical CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Nutraceutical CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Nutraceutical CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 49. Catalent Company Details
Table 50. Catalent Business Overview
Table 51. Catalent Nutraceutical CDMO Product
Table 52. Catalent Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 53. Catalent Recent Development
Table 54. Lonza Company Details
Table 55. Lonza Business Overview
Table 56. Lonza Nutraceutical CDMO Product
Table 57. Lonza Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 58. Lonza Recent Development
Table 59. Aenova Group Company Details
Table 60. Aenova Group Business Overview
Table 61. Aenova Group Nutraceutical CDMO Product
Table 62. Aenova Group Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 63. Aenova Group Recent Development
Table 64. Akums Drugs and Pharmaceutical Company Details
Table 65. Akums Drugs and Pharmaceutical Business Overview
Table 66. Akums Drugs and Pharmaceutical Nutraceutical CDMO Product
Table 67. Akums Drugs and Pharmaceutical Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 68. Akums Drugs and Pharmaceutical Recent Development
Table 69. BASF SE Company Details
Table 70. BASF SE Business Overview
Table 71. BASF SE Nutraceutical CDMO Product
Table 72. BASF SE Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 73. BASF SE Recent Development
Table 74. Sirio Pharm Company Details
Table 75. Sirio Pharm Business Overview
Table 76. Sirio Pharm Nutraceutical CDMO Product
Table 77. Sirio Pharm Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 78. Sirio Pharm Recent Development
Table 79. Pharmavite Company Details
Table 80. Pharmavite Business Overview
Table 81. Pharmavite Nutraceutical CDMO Product
Table 82. Pharmavite Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 83. Pharmavite Recent Development
Table 84. Nature's Products Company Details
Table 85. Nature's Products Business Overview
Table 86. Nature's Products Nutraceutical CDMO Product
Table 87. Nature's Products Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 88. Nature's Products Recent Development
Table 89. PLT Health Solutions Company Details
Table 90. PLT Health Solutions Business Overview
Table 91. PLT Health Solutions Nutraceutical CDMO Product
Table 92. PLT Health Solutions Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 93. PLT Health Solutions Recent Development
Table 94. Glanbia Nutritionals Company Details
Table 95. Glanbia Nutritionals Business Overview
Table 96. Glanbia Nutritionals Nutraceutical CDMO Product
Table 97. Glanbia Nutritionals Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 98. Glanbia Nutritionals Recent Development
Table 99. Recipharm AB Company Details
Table 100. Recipharm AB Business Overview
Table 101. Recipharm AB Nutraceutical CDMO Product
Table 102. Recipharm AB Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 103. Recipharm AB Recent Development
Table 104. B&D Nutritional Ingredients Company Details
Table 105. B&D Nutritional Ingredients Business Overview
Table 106. B&D Nutritional Ingredients Nutraceutical CDMO Product
Table 107. B&D Nutritional Ingredients Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 108. B&D Nutritional Ingredients Recent Development
Table 109. NutraScience Labs Company Details
Table 110. NutraScience Labs Business Overview
Table 111. NutraScience Labs Nutraceutical CDMO Product
Table 112. NutraScience Labs Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 113. NutraScience Labs Recent Development
Table 114. Vitakem Nutraceutical Company Details
Table 115. Vitakem Nutraceutical Business Overview
Table 116. Vitakem Nutraceutical Nutraceutical CDMO Product
Table 117. Vitakem Nutraceutical Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 118. Vitakem Nutraceutical Recent Development
Table 119. Procaps Group Company Details
Table 120. Procaps Group Business Overview
Table 121. Procaps Group Nutraceutical CDMO Product
Table 122. Procaps Group Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 123. Procaps Group Recent Development
Table 124. Iprona Company Details
Table 125. Iprona Business Overview
Table 126. Iprona Nutraceutical CDMO Product
Table 127. Iprona Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 128. Iprona Recent Development
Table 129. Nutrilo GmbH Company Details
Table 130. Nutrilo GmbH Business Overview
Table 131. Nutrilo GmbH Nutraceutical CDMO Product
Table 132. Nutrilo GmbH Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 133. Nutrilo GmbH Recent Development
Table 134. Atlantic Essential Products Company Details
Table 135. Atlantic Essential Products Business Overview
Table 136. Atlantic Essential Products Nutraceutical CDMO Product
Table 137. Atlantic Essential Products Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 138. Atlantic Essential Products Recent Development
Table 139. ProTec Nutra Company Details
Table 140. ProTec Nutra Business Overview
Table 141. ProTec Nutra Nutraceutical CDMO Product
Table 142. ProTec Nutra Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 143. ProTec Nutra Recent Development
Table 144. Nutraceuticals International Company Details
Table 145. Nutraceuticals International Business Overview
Table 146. Nutraceuticals International Nutraceutical CDMO Product
Table 147. Nutraceuticals International Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 148. Nutraceuticals International Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
Table 152. Authors List of This Report
List of Figures
Figure 1. Nutraceutical CDMO Picture
Figure 2. Global Nutraceutical CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nutraceutical CDMO Market Share by Type: 2024 VS 2031
Figure 4. Tablets & Capsules Features
Figure 5. Powder Features
Figure 6. Softgel Features
Figure 7. Liquid Formulations Features
Figure 8. Other Features
Figure 9. Global Nutraceutical CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Nutraceutical CDMO Market Share by Application: 2024 VS 2031
Figure 11. Small Companies Case Studies
Figure 12. Mid-sized Companies Case Studies
Figure 13. Large Companies Case Studies
Figure 14. Nutraceutical CDMO Report Years Considered
Figure 15. Global Nutraceutical CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Nutraceutical CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Nutraceutical CDMO Market Share by Region: 2024 VS 2031
Figure 18. Global Nutraceutical CDMO Market Share by Players in 2024
Figure 19. Global Nutraceutical CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Nutraceutical CDMO Revenue in 2024
Figure 21. North America Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Nutraceutical CDMO Market Share by Country (2020-2031)
Figure 23. United States Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Nutraceutical CDMO Market Share by Country (2020-2031)
Figure 27. Germany Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Ireland Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Nutraceutical CDMO Market Share by Region (2020-2031)
Figure 35. China Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia & New Zealand Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Nutraceutical CDMO Market Share by Country (2020-2031)
Figure 43. Mexico Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Nutraceutical CDMO Market Share by Country (2020-2031)
Figure 47. Israel Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Catalent Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 51. Lonza Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 52. Aenova Group Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 53. Akums Drugs and Pharmaceutical Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 54. BASF SE Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 55. Sirio Pharm Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 56. Pharmavite Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 57. Nature's Products Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 58. PLT Health Solutions Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 59. Glanbia Nutritionals Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 60. Recipharm AB Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 61. B&D Nutritional Ingredients Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 62. NutraScience Labs Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 63. Vitakem Nutraceutical Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 64. Procaps Group Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 65. Iprona Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 66. Nutrilo GmbH Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 67. Atlantic Essential Products Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 68. ProTec Nutra Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 69. Nutraceuticals International Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Table 1. Global Nutraceutical CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Tablets & Capsules
Table 3. Key Players of Powder
Table 4. Key Players of Softgel
Table 5. Key Players of Liquid Formulations
Table 6. Key Players of Other
Table 7. Global Nutraceutical CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Nutraceutical CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Nutraceutical CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Nutraceutical CDMO Market Share by Region (2020-2025)
Table 11. Global Nutraceutical CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Nutraceutical CDMO Market Share by Region (2026-2031)
Table 13. Nutraceutical CDMO Market Trends
Table 14. Nutraceutical CDMO Market Drivers
Table 15. Nutraceutical CDMO Market Challenges
Table 16. Nutraceutical CDMO Market Restraints
Table 17. Global Nutraceutical CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Nutraceutical CDMO Market Share by Players (2020-2025)
Table 19. Global Top Nutraceutical CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nutraceutical CDMO as of 2024)
Table 20. Ranking of Global Top Nutraceutical CDMO Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Nutraceutical CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Nutraceutical CDMO, Headquarters and Area Served
Table 23. Global Key Players of Nutraceutical CDMO, Product and Application
Table 24. Global Key Players of Nutraceutical CDMO, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nutraceutical CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Nutraceutical CDMO Revenue Market Share by Type (2020-2025)
Table 28. Global Nutraceutical CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Nutraceutical CDMO Revenue Market Share by Type (2026-2031)
Table 30. Global Nutraceutical CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Nutraceutical CDMO Revenue Market Share by Application (2020-2025)
Table 32. Global Nutraceutical CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Nutraceutical CDMO Revenue Market Share by Application (2026-2031)
Table 34. North America Nutraceutical CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Nutraceutical CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Nutraceutical CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Nutraceutical CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Nutraceutical CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Nutraceutical CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Nutraceutical CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Nutraceutical CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Nutraceutical CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Nutraceutical CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Nutraceutical CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Nutraceutical CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Nutraceutical CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Nutraceutical CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Nutraceutical CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 49. Catalent Company Details
Table 50. Catalent Business Overview
Table 51. Catalent Nutraceutical CDMO Product
Table 52. Catalent Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 53. Catalent Recent Development
Table 54. Lonza Company Details
Table 55. Lonza Business Overview
Table 56. Lonza Nutraceutical CDMO Product
Table 57. Lonza Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 58. Lonza Recent Development
Table 59. Aenova Group Company Details
Table 60. Aenova Group Business Overview
Table 61. Aenova Group Nutraceutical CDMO Product
Table 62. Aenova Group Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 63. Aenova Group Recent Development
Table 64. Akums Drugs and Pharmaceutical Company Details
Table 65. Akums Drugs and Pharmaceutical Business Overview
Table 66. Akums Drugs and Pharmaceutical Nutraceutical CDMO Product
Table 67. Akums Drugs and Pharmaceutical Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 68. Akums Drugs and Pharmaceutical Recent Development
Table 69. BASF SE Company Details
Table 70. BASF SE Business Overview
Table 71. BASF SE Nutraceutical CDMO Product
Table 72. BASF SE Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 73. BASF SE Recent Development
Table 74. Sirio Pharm Company Details
Table 75. Sirio Pharm Business Overview
Table 76. Sirio Pharm Nutraceutical CDMO Product
Table 77. Sirio Pharm Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 78. Sirio Pharm Recent Development
Table 79. Pharmavite Company Details
Table 80. Pharmavite Business Overview
Table 81. Pharmavite Nutraceutical CDMO Product
Table 82. Pharmavite Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 83. Pharmavite Recent Development
Table 84. Nature's Products Company Details
Table 85. Nature's Products Business Overview
Table 86. Nature's Products Nutraceutical CDMO Product
Table 87. Nature's Products Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 88. Nature's Products Recent Development
Table 89. PLT Health Solutions Company Details
Table 90. PLT Health Solutions Business Overview
Table 91. PLT Health Solutions Nutraceutical CDMO Product
Table 92. PLT Health Solutions Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 93. PLT Health Solutions Recent Development
Table 94. Glanbia Nutritionals Company Details
Table 95. Glanbia Nutritionals Business Overview
Table 96. Glanbia Nutritionals Nutraceutical CDMO Product
Table 97. Glanbia Nutritionals Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 98. Glanbia Nutritionals Recent Development
Table 99. Recipharm AB Company Details
Table 100. Recipharm AB Business Overview
Table 101. Recipharm AB Nutraceutical CDMO Product
Table 102. Recipharm AB Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 103. Recipharm AB Recent Development
Table 104. B&D Nutritional Ingredients Company Details
Table 105. B&D Nutritional Ingredients Business Overview
Table 106. B&D Nutritional Ingredients Nutraceutical CDMO Product
Table 107. B&D Nutritional Ingredients Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 108. B&D Nutritional Ingredients Recent Development
Table 109. NutraScience Labs Company Details
Table 110. NutraScience Labs Business Overview
Table 111. NutraScience Labs Nutraceutical CDMO Product
Table 112. NutraScience Labs Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 113. NutraScience Labs Recent Development
Table 114. Vitakem Nutraceutical Company Details
Table 115. Vitakem Nutraceutical Business Overview
Table 116. Vitakem Nutraceutical Nutraceutical CDMO Product
Table 117. Vitakem Nutraceutical Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 118. Vitakem Nutraceutical Recent Development
Table 119. Procaps Group Company Details
Table 120. Procaps Group Business Overview
Table 121. Procaps Group Nutraceutical CDMO Product
Table 122. Procaps Group Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 123. Procaps Group Recent Development
Table 124. Iprona Company Details
Table 125. Iprona Business Overview
Table 126. Iprona Nutraceutical CDMO Product
Table 127. Iprona Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 128. Iprona Recent Development
Table 129. Nutrilo GmbH Company Details
Table 130. Nutrilo GmbH Business Overview
Table 131. Nutrilo GmbH Nutraceutical CDMO Product
Table 132. Nutrilo GmbH Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 133. Nutrilo GmbH Recent Development
Table 134. Atlantic Essential Products Company Details
Table 135. Atlantic Essential Products Business Overview
Table 136. Atlantic Essential Products Nutraceutical CDMO Product
Table 137. Atlantic Essential Products Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 138. Atlantic Essential Products Recent Development
Table 139. ProTec Nutra Company Details
Table 140. ProTec Nutra Business Overview
Table 141. ProTec Nutra Nutraceutical CDMO Product
Table 142. ProTec Nutra Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 143. ProTec Nutra Recent Development
Table 144. Nutraceuticals International Company Details
Table 145. Nutraceuticals International Business Overview
Table 146. Nutraceuticals International Nutraceutical CDMO Product
Table 147. Nutraceuticals International Revenue in Nutraceutical CDMO Business (2020-2025) & (US$ Million)
Table 148. Nutraceuticals International Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
Table 152. Authors List of This Report
List of Figures
Figure 1. Nutraceutical CDMO Picture
Figure 2. Global Nutraceutical CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nutraceutical CDMO Market Share by Type: 2024 VS 2031
Figure 4. Tablets & Capsules Features
Figure 5. Powder Features
Figure 6. Softgel Features
Figure 7. Liquid Formulations Features
Figure 8. Other Features
Figure 9. Global Nutraceutical CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Nutraceutical CDMO Market Share by Application: 2024 VS 2031
Figure 11. Small Companies Case Studies
Figure 12. Mid-sized Companies Case Studies
Figure 13. Large Companies Case Studies
Figure 14. Nutraceutical CDMO Report Years Considered
Figure 15. Global Nutraceutical CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Nutraceutical CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Nutraceutical CDMO Market Share by Region: 2024 VS 2031
Figure 18. Global Nutraceutical CDMO Market Share by Players in 2024
Figure 19. Global Nutraceutical CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Nutraceutical CDMO Revenue in 2024
Figure 21. North America Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Nutraceutical CDMO Market Share by Country (2020-2031)
Figure 23. United States Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Nutraceutical CDMO Market Share by Country (2020-2031)
Figure 27. Germany Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Ireland Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Nutraceutical CDMO Market Share by Region (2020-2031)
Figure 35. China Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia & New Zealand Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Nutraceutical CDMO Market Share by Country (2020-2031)
Figure 43. Mexico Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Nutraceutical CDMO Market Share by Country (2020-2031)
Figure 47. Israel Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Nutraceutical CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Catalent Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 51. Lonza Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 52. Aenova Group Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 53. Akums Drugs and Pharmaceutical Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 54. BASF SE Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 55. Sirio Pharm Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 56. Pharmavite Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 57. Nature's Products Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 58. PLT Health Solutions Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 59. Glanbia Nutritionals Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 60. Recipharm AB Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 61. B&D Nutritional Ingredients Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 62. NutraScience Labs Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 63. Vitakem Nutraceutical Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 64. Procaps Group Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 65. Iprona Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 66. Nutrilo GmbH Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 67. Atlantic Essential Products Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 68. ProTec Nutra Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 69. Nutraceuticals International Revenue Growth Rate in Nutraceutical CDMO Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232